Those who succeed in market access today - are those seizing the initiative and finding creative ways to work with the external environment. They are also re-shaping their internal structure to produce the best therapy narrative.
What does this all mean? Internally it’s about moving from a concept of research and development to value based development. Externally it is everything to do with identifying stakeholder’s priorities and motivations to achieve the best possible outcomes for market access strategies.
With valuable insights from Lundbeck, Astellas, Janssen and Takeda, download our free feature magazine today, as we discuss:
• The growing importance of market access in creating a commercial value proposition
• The evolving pharma- payer relationship
• How pharma can position as best in class partners to support payers battling with affordability
Access your copy here: https://goo.gl/Hi7e2j